$64.08
3.676.07%
Last update: Nov 4, 1:09 PM
AtriCure Inc (ATRC) Stock Price, Quote, News & History
ATRCNASDAQ
AtriCure beat Q3 estimates, raised FY2026 EPS and sales guidance, and saw analysts lift price targets to $70; shares fell 2%.
You can purchase shares of AtriCure (NASDAQ:ATRC) through any online brokerage.
Other companies in AtriCure’s space includes: Abbott Laboratories (NYSE:ABT), Intuitive Surgical Inc (NASDAQ:ISRG), Medtronic PLC (NYSE:MDT), Stryker Corp (NYSE:SYK) and Boston Scientific Corp (NYSE:BSX).
AtriCure has a consensus price target of $58.14.
The stock price for AtriCure (NASDAQ: ATRC) is $64.075 last updated November 4, 2026 at 1:09 PM EST.
There are no upcoming dividends for AtriCure.
AtriCure does not have any upcoming earnings scheduled.
There is no upcoming split for AtriCure.
AtriCure is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and...
